drugset / Trial / NCT00330876

Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

NCT00330876

Phase 3 Completed 545 enrolled Kowa Research Europe
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is an open-label extension study of NK-104-306 (NCT00257686) for elderly patients with hypercholesterolemia or combined dyslipidemia.

Timeline

Start
2006-06
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitavastatin Small molecule 2 mg
Subject Pitavastatin Small molecule 4 mg

Indications